Literature DB >> 19357299

The licensing of medicines in the UK.

.   

Abstract

Before a medicinal product* can be marketed in the UK, a marketing authorisation (formerly called a 'product licence') is needed. Such an authorisation can be granted in the European Union (EU), via the European Medicines Agency (EMEA), European Commission (EC) and member state's competent authorities or, specifically in the UK, via the Medicines and Healthcare product Regulatory Agency (MHRA) on behalf of the UK licensing authority.2(-)4 Also, a change to the authorisation is needed if the licensing status of a medicine is changed; for example, from a prescription-only medicine (POM) to a pharmacy medicine (P). Here we look at the procedures involved in the licensing of medicines (including herbal and homoeopathic products) for use in the UK.

Mesh:

Substances:

Year:  2009        PMID: 19357299     DOI: 10.1136/dtb.2009.03.0012

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  2 in total

1.  Regulating medicines in Croatia: five-year experience of Agency for Medicinal Products and Medical Devices.

Authors:  Sinisa Tomić; Anita Filipović Sucić; Ana Plazonić; Rajka Truban Zulj; Viola Macolić Sarinić; Branka Cudina; Adrijana Ilić Martinac
Journal:  Croat Med J       Date:  2010-04       Impact factor: 1.351

2.  An overview of nuclear medicine research in the UK and the landscape for clinical adoption.

Authors:  Jennifer D Young; Maite Jauregui-Osoro; Wai-Lup Wong; Margaret S Cooper; Gary Cook; Sally F Barrington; Michelle T Ma; Philip J Blower; Eric O Aboagye
Journal:  Nucl Med Commun       Date:  2021-12-01       Impact factor: 1.690

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.